<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02534974</url>
  </required_header>
  <id_info>
    <org_study_id>AGATE</org_study_id>
    <nct_id>NCT02534974</nct_id>
  </id_info>
  <brief_title>Impact of the Addition of a Device Providing Continuous Pneumatic Regulation of Tube Cuff Pressure to an Overall Strategy Aimed at Preventing Ventilator-associated Pneumonia in the Severe Trauma Patient. A Multicentre, Randomised, Controlled Study.</brief_title>
  <acronym>AGATE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <brief_summary>
    <textblock>
      Ventilation-associated pneumonia is the main site of healthcare-associated infections in the&#xD;
      severe trauma patient, with a mean incidence rate of 35%. Ventilator-associated pneumonia&#xD;
      increases morbi-mortality, length of stay in intensive care and overall management costs. As&#xD;
      was recalled by the jury of the 2008 SFAR-SRLF consensus conference on the prevention of&#xD;
      nosocomial infections contracted in intensive care, success in this preventive endeavour&#xD;
      depends on a number of measures: orotracheal intubation route, maintaining tube cuff pressure&#xD;
      between 25 and 30 cm H2O, maintaining a semi-seated position ≥30°, nasal and oropharyngeal&#xD;
      care at regular intervals, striving to avoid unscheduled extubation, and use of a written&#xD;
      sedation-analgesia algorithm allowing for early weaning from ventilation.&#xD;
&#xD;
      Devices ensuring continuous pneumatic control of tube cuff pressure are more efficient in&#xD;
      maintaining tracheal balloon pressure than intermittent adjustments using a hand-held&#xD;
      manometer. In one study, these devices clearly facilitated diminution of microaspiration of&#xD;
      gastric contents and of ventilator-associated pneumonia incidence density (9.7 vs. 22&#xD;
      VAP/1000 days of mechanical ventilation; p = 0.005).&#xD;
&#xD;
      The investigators are putting forward the hypothesis that by adjoining a device providing&#xD;
      continuous pneumatic regulation of tube cuff pressure to an overall strategy aimed at&#xD;
      ventilator-associated pneumonia prevention (including semi-recumbent position ≥30°,&#xD;
      oro-nasal-pharyngeal care at regular intervals and reduced risk exposure) can decrease VAP&#xD;
      incidence by 50% in severely traumatised patients whose condition necessitates mechanical&#xD;
      ventilation of an expected duration exceeding 48h.&#xD;
&#xD;
      Ours is the first large-scale study to evaluate the interest of an innovative technology&#xD;
      bundle on decrease of ventilator-associated pneumonia incidence in one of the intensive care&#xD;
      populations the most at risk, namely severe trauma patients, a population presently&#xD;
      benefiting from the other recommended preventive measures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 31, 2015</start_date>
  <completion_date type="Actual">April 11, 2018</completion_date>
  <primary_completion_date type="Actual">February 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients having developed VAP at D28 in intensive care according to the ATS definition</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients having developed VAP in ICU according to the ATS definition</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients having developed early (≤ day 7) or late (&gt; day 7) VAP in ICU according to the ATS definition</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first episode of VAP diagnosis according to the ATS definition</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients developing ventilator-associated events (VAE) according to the CDC definition</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of ventilator free days</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of antibiotic free days</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length-of-stay</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patient who died during their ICU stay</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring corticosteroids or bronchodilators within 48 hours of tracheal extubation</measure>
    <time_frame>max 60 days</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">440</enrollment>
  <condition>Ventilation-associated Pneumonia</condition>
  <condition>Severe Trauma Patient</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NOSTEN</intervention_name>
    <other_name>device providing continuous pneumatic regulation of tube cuff pressure</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients having a severe trauma as defined by an Injury Severity Score (ISS) &gt;15,&#xD;
&#xD;
          -  Aged at least 18 years,&#xD;
&#xD;
          -  Intubated for less than 15h,&#xD;
&#xD;
          -  Necessitating recourse to mechanical ventilation for an expected period ≥ 48h,&#xD;
&#xD;
          -  Participating in a social security scheme or benefiting from such a scheme by means of&#xD;
             a third party.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient likely to die over the 48h following admission,&#xD;
&#xD;
          -  Nasotracheal intubation,&#xD;
&#xD;
          -  Patient intubated through a tracheal tube with subglottic secretion drainage&#xD;
&#xD;
          -  Intubation carried out 24h or more after the trauma,&#xD;
&#xD;
          -  Ventilation with tracheotomy,&#xD;
&#xD;
          -  Refusal to participate in the research,&#xD;
&#xD;
          -  Contraindication to the head-up position,&#xD;
&#xD;
          -  Participation in another research protocol focusing on an anti-infective treatment or&#xD;
             on a measure decreasing the risk of infection,&#xD;
&#xD;
          -  Persons benefiting from reinforced protection or persons deprived of freedom&#xD;
             subsequent to a legal or administrative decision, minors under legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sigismond LASOCKI</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sébastien PILI FLOURY</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jean Michel CONSTANTIN</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catherine PAUGAM</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Belaid BOUHEMAD</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dominique FALCON</name>
      <address>
        <city>Grenoble</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marc LEONE</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karim ASEHNOUNE</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carole ICHAI</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jean Yves LEFRANT</name>
      <address>
        <city>Nîmes</city>
        <zip>30900</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Olivier MIMOZ</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Benoit VEBER</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Julien POTTECHER</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>July 28, 2015</study_first_submitted>
  <study_first_submitted_qc>August 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2015</study_first_posted>
  <last_update_submitted>April 24, 2019</last_update_submitted>
  <last_update_submitted_qc>April 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critical care</keyword>
  <keyword>Trauma patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

